A QYourVenture company co-founded by researchers in the Eye Movement Lab at the Faculty of Health Sciences were selected for the INOVAIT Pilot Fund to advance their startup venture, Dynamiris.
Co-founders Dr. Doug Munoz, Dr. Janis Kan, Don Brien, Brian White, and Dr. Brian Coe are developing a revolutionary solution to enhance the diagnosis and monitoring of neurological disorders. By harnessing the power of eye-tracking technology and an advanced AI classifier, they have created a highly sensitive and objective tool that holds great promise for early detection of brain disorders. "We envision this system providing an end-to-end product that is easy to administer, even in remote locations where access to neurologists may be limited," Dr. Janis Kan explained.
INOVAIT, the pan-Canadian network for image-guided therapy (IGT) hosted by Sunnybrook Research Institute (SRI) and funded by the Government of Canada’s Strategic Innovation Fund, awarded 14 projects that are part of the third round of its Pilot Fund.
The Dynamiris team previously won the top prize in the Mitacs Invention to Innovation (i2I) competition that awards excellence in commercializing science and technology. DDQIC assists Mitacs, the Faculty of Engineering and Applied Science, and Simon Fraser University in delivering i2I.
The funding and support Dynamiris has achieved will accelerate their path to transform treatment strategies and significantly improve patient outcomes.
